Latest MS research news

Latest MS research news | 28 January 2014

Modest familial risks for MS: a registry-based study of the population of Sweden

MS is a complex disease with more than one hundred risk associated genes identified to date. This study looked at the familial recurrence risks of MS. Overall the results demonstrated lower risk ratios than most previous studies of familial recurrences in multiple sclerosis to date.

From MSIF

Latest MS research news | 28 January 2014

Safety and efficacy of ofatumumab in relapsing-remitting MS: A phase 2 study

This clinical trial looked at ofatumumab in patients with relapsing remitting MS, to assess both the safety and the efficacy of the drug.

From MSIF

Latest MS research news | 21 January 2014

Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions

In this study the researchers quantified this neurotransmitter (glutamate) in specific regions of the brain and investigated if there was a relationship between the concentration of this neurotransmitter and memory performance in subjects with relapsing-remitting MS.

From MSIF

Latest MS research news | 21 January 2014

Immunotherapies influence the influenza vaccination response in MS patients: an explorative study

The researchers in this study demonstrated that MS patients receiving immunomodulatory therapy (glatiramer acetate, natalizumab and mitoxantrone) had a reduced rate of protection to the seasonal influenza vaccine. Patients receiving interferon therapy did not demonstrate reduced protection.

From MSIF

Latest MS research news | 21 January 2014

Intervention for increasing exercise behaviour and improving health outcomes

This study demonstrates improvements in self-directed exercise behaviour, health related quality of life and fatigue.

From MSIF

Latest MS research news | 14 January 2014

Motor and sensory responses after percutaneous tibial nerve stimulation in MS patients with lower urinary tract symptoms

This study looked at the use of posterior tibial nerve stimulation (PTNS) in MS subjects unresponsive to medical treatment.

From MSIF

Latest MS research news | 14 January 2014

Colour vision impairment is associated with disease severity in multiple sclerosis

This study showed that impaired colour in the eyes of MS patients who have not previously suffered optic neuritis is associated with increased clinical disability.

From MSIF

Latest MS research news | 14 January 2014

Postpartum relapses increase the risk of disability progression in MS: the role of disease modifying drugs

This study found that patients with higher disability at conception and higher relapse rate pre-pregnancy and during pregnancy were at a higher risk of relapse post-delivery.

From MSIF

Latest MS research news | 07 January 2014

Reduced sick leave in multiple sclerosis after one year of natalizumab treatment

This study group looked at the amount of sick leave in subjects with relapsing remitting MS (RRMS) before and one year after treatment with natalizumab (Tysabri).

From MSIF

Latest MS research news | 07 January 2014

Hemodynamic evidence linking cognitive deficits in clinically isolated syndrome to brain inflammation

This study looked at changes in cerebral blood flow and volume on MRI in subjects with a clinically isolated syndrome, and the relationship between these changes on MRI and memory function.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial